In daily practice, oncology professionals have both professional and operational goals, such as facilitating access to patient records and improving evaluation and management documentation. Some institutions may take into consideration financial requirements, like decreasing overhead costs associated with chart pulls and supplies, as well as decreasing medical transcription costs. ESMO recognises the importance of developing and providing its members with resources to respond to these needs.
Disease-specific and general prognostic and predictive tools
- Colorectal Cancer Prognosis
- IPI, FLIPI, IELSG-CNS index for lymphoma
- Germ cell tumors risk groups
- Hasenclever-Index for Hodgkin's disease
- Paravasate of cytostatic drugs
- Treatment algorithm for stage IV NSCLC
- Karnofsky & ECOG Scores
After inserting your patient characteristics into templates of our interactive tools, at the end you will find calculated result, projection or corresponding category. You have also the possibility to print sheets and insert them into medical files.
Body Surface Area calculator
The body surface area (BSA) is used in many measurements, including the calculation of drug dosages and the amount of fluids to be administered iv. The BSA Calculator tool will assist oncologists with the appropriate dose of chemotherapy.
Creatinine Clearance - AUC-dosing Calculator
The area under curve (AUC) dosing calculator is a practice tool which gives oncologists the ability to calculate creatinine clearance and the desided AUC to determine proper drug dose.
Calculation of PSA doubling time
Prostate specific antigen (PSA) doubling time (PSA-DT) has been identified as a strong prognostic indicator at the time of diagnosis of prostate cancer, and as a strong predictor of survival when measured at the time of recurrence after prostatectomy and radiation therapy. Measurements of PSA kinetics assists in estimating prognosis once an initial diagnosis is established.
Evaluation of risk of metastases prior to radical therapy of prostate cancer
This practice tool assists oncologists in the evaluation of risk of metastasis prior to radical therapy of prostate cancer. The value could be the treatment tailored to risk.
Treatment response evaluation
After inserting your patient characteristics into the spreadsheet, you should find at the bottom the calculated projection and the corresponding category of response assessment. On separate sheets, it’s possible to calculate a response according to WHO and RECIST (version 1.0) criteria.